PSUF
JAZZ icon

People's United Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

People's United Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$810K Sell
5,204
-300
-5% -$43.5K 0.02% 360
2021
Q4 		$701K Buy
5,504
+122
+2% +$16K 0.02% 424
2021
Q3 		$701K Sell
5,382
-97
-2% -$14.7K 0.02% 447
2021
Q2 		$973K Buy
5,479
+546
+11% +$94.6K 0.02% 391
2021
Q1 		$811K Buy
4,933
+441
+10% +$72.6K 0.02% 401
2020
Q4 		$741K Buy
4,492
+219
+5% +$32.6K 0.02% 389
2020
Q3 		$609K Buy
4,273
+159
+4% +$19.7K 0.02% 394
2020
Q2 		$454K Buy
4,114
+797
+24% +$88.1K 0.01% 442
2020
Q1 		$331K Buy
3,317
+969
+41% +$125K 0.01% 458
2019
Q4 		$351K Buy
2,348
+80
+4% +$10.9K 0.01% 592
2019
Q3 		$291K Buy
2,268
+56
+3% +$7.51K 0.01% 634
2019
Q2 		$315K Sell
2,212
-1,025
-32% -$138K 0.01% 635
2019
Q1 		$460K Buy
+3,237
New +$422K 0.01% 538
2016
Q4 		– Sell
-115
Closed -$14K – 1034
2016
Q3 		$14K Hold
115
– – ﹤0.01% 704
2016
Q2 		$16K Buy
+115
New +$17K ﹤0.01% 689

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

People's United Financial's JAZZ Position: Q1 2022 in Review

People's United Financial reduced its Jazz Pharmaceuticals (JAZZ) stake by 5.5% in Q1 2022, selling an estimated $43.5K and leaving 5,204 shares worth $810K. The position accounts for 0.02% of the portfolio, ranked #360.

People's United Financial first reported a position in JAZZ in Q2 2016 and has held it in 15 quarters since. The position peaked at $973K in Q2 2021. 461 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

  • People's United Financial held 5,204 shares of Jazz Pharmaceuticals worth $810K as of Q1 2022.
  • People's United Financial sold 300 Jazz Pharmaceuticals shares in Q1 2022, an estimated $43.5K.
  • Jazz Pharmaceuticals made up 0.02% of People's United Financial's portfolio in Q1 2022, its #360 holding.
  • People's United Financial first reported a position in Jazz Pharmaceuticals in Q2 2016 and has held it in 15 quarters since.
  • People's United Financial's Jazz Pharmaceuticals position peaked at $973K in Q2 2021.
  • 461 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.